Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring
NCT00836212Phase 4Unknown
- Start
- Mar 2008
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of efavirenz, lopinavir in human immunodeficiency virus infection (HIV). Status: unknown.
02
Drugs
efavirenzlopinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00836212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00836212.